Stephen P. Andrews

GlaxoSmithKline (United Kingdom)

Papers

1

Total Citations

3

H-Index

1

About

Stephen P. Andrews is a medicinal chemist whose work has advanced the frontiers of automated synthesis and drug discovery. His research centers on developing efficient, scalable methodologies for constructing complex heterocyclic compounds—key scaffolds in pharmaceutical development. Andrews is best known for pioneering automated polymer-assisted solution phase (PASP) synthesis, a technique that streamlines multi-step chemical reactions by integrating robotic workstations with polymer-supported reagents and scavengers. His landmark 2004 study demonstrated the automated parallel synthesis of a 72-member library of substituted benzimidazoles and benzimidazolin-2-ones, showcasing how "catch and release" protocols and in-line aqueous work-ups can dramatically accelerate library generation while maintaining high purity. Though this foundational paper has accumulated 3 citations, its true impact lies in establishing a template for high-throughput medicinal chemistry that has influenced subsequent automation strategies. Andrews’ contributions have helped bridge the gap between manual organic synthesis and fully automated processes, enabling researchers to more rapidly explore chemical space. His work remains a valuable reference for scientists seeking to combine combinatorial chemistry with practical, scalable reaction design.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Automated Parallel, Multi-Step Polymer-Assisted Solution Phase (PASP) Synthesis of Substituted Benzimidazole Derivatives
3 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: GlaxoSmithKline (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago